| scholarly article | Q13442814 |
| P50 | author | Ikuo Tsunoda | Q47558756 |
| P2093 | author name string | Robert S Fujinami | |
| Jane E Libbey | |||
| Emily Jane Terry | |||
| Li-Qing Kuang | |||
| P2860 | cites work | Defining the clinical course of multiple sclerosis: Results of an international survey | Q22241638 |
| B lymphocytes express and lose syndecan at specific stages of differentiation | Q24596510 | ||
| Structure and evolution of the extended B7 family | Q28198042 | ||
| Disruption of the Bcl6 gene results in an impaired germinal center formation | Q28509600 | ||
| A receptor for phosphatidylserine-specific clearance of apoptotic cells | Q28586441 | ||
| Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa | Q30453882 | ||
| Splenic atrophy in systemic lupus erythematosus | Q33484079 | ||
| Systemic Lupus Erythematosus and Thymoma – A Double-Edged Sword | Q33488979 | ||
| Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. | Q33914297 | ||
| Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis | Q34155199 | ||
| Apoptosis in sepsis: a new target for therapeutic exploration | Q34211981 | ||
| Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis | Q34223823 | ||
| Mast cells: new targets for multiple sclerosis therapy? | Q35012299 | ||
| Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis. | Q35076301 | ||
| T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis | Q35103323 | ||
| Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases | Q35216386 | ||
| Axonal injury heralds virus-induced demyelination. | Q35749193 | ||
| NKT cells are relatively resistant to apoptosis | Q35751884 | ||
| Murine models of systemic lupus erythematosus | Q69894910 | ||
| High frequency of mast cells in spleens of A-strain mice | Q70078202 | ||
| Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma | Q70379216 | ||
| Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice | Q71656870 | ||
| Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma | Q71740175 | ||
| Pathological changes of thymic epithelial cells and autoimmune disease in NZB, NZW and (NZB x NZW)F1 mice | Q72209408 | ||
| Comparative Effects of Some Immunosuppressive and Anti-Inflammatory Drugs on Allergic Encephalomyelitis and Adjuvant Arthritis | Q72226125 | ||
| A comparison of the pathology of primary and secondary progressive multiple sclerosis | Q72708285 | ||
| Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells | Q73202021 | ||
| Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains | Q73967093 | ||
| Genetic and epigenetic influence on EAE phenotypes induced with different encephalitogenic peptides | Q74016806 | ||
| Is IgG2a a good Th1 marker in mice? | Q74181221 | ||
| A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction | Q74237342 | ||
| Lipopeptide particles as the immunologically active component of CTL inducing vaccines | Q74586012 | ||
| Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA | Q77162060 | ||
| Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis | Q78608096 | ||
| Converting relapsing remitting to secondary progressive experimental allergic encephalomyelitis (EAE) by ultraviolet B irradiation | Q81400436 | ||
| Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. | Q35834262 | ||
| Extending the B7 (CD80) gene family | Q36278785 | ||
| Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease | Q36380402 | ||
| Systemic exposure to irradiated apoptotic cells induces autoantibody production | Q36401434 | ||
| 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. | Q37322604 | ||
| BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death | Q37572590 | ||
| Functional asplenia in systemic lupus erythematosus | Q38033518 | ||
| Mast cells in mammalian brain. | Q38706439 | ||
| Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen | Q39632397 | ||
| Release and inactivation of interleukin-4 by mast cells | Q40671533 | ||
| Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis | Q41588487 | ||
| Chemotherapy of experimental allergic encephalomyelitis (EAE) | Q41939154 | ||
| Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation | Q41957968 | ||
| Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study | Q42506123 | ||
| Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats | Q42538962 | ||
| The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes | Q43467470 | ||
| Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis | Q44027997 | ||
| Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant | Q44259814 | ||
| Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice | Q44904989 | ||
| Apoptosis of infiltrating T cells in the central nervous system of mice infected with Theiler's murine encephalomyelitis virus. | Q45710561 | ||
| Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. | Q45758858 | ||
| Effects of experimental allergic encephalomyelitis on thymus and adrenal: relation to remission and relapse | Q46624085 | ||
| Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course | Q47581695 | ||
| Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes | Q47593158 | ||
| Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains | Q47774802 | ||
| The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice. | Q47809273 | ||
| Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. | Q48154504 | ||
| Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse | Q48532989 | ||
| Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice | Q48648759 | ||
| A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes | Q49019689 | ||
| Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement | Q49049540 | ||
| IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis | Q49129042 | ||
| Severe T-cell depletion from the PALS leads to altered spleen composition in common marmosets with experimental autoimmune encephalomyelitis (EAE). | Q50773213 | ||
| Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. | Q54198068 | ||
| Sepsis-induced apoptosis of the thymocytes in mice. | Q54633402 | ||
| Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction | Q57773627 | ||
| Immunosuppressive effects of apoptotic cells | Q59060221 | ||
| Spinal cord atrophy and disability in MS: A longitudinal study | Q62601721 | ||
| Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis | Q63535310 | ||
| Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein | Q63535313 | ||
| Experimental allergic encephalomyelitis. — The effect of dexamethasone on growth and proliferation in the draining lymph node> | Q66889952 | ||
| Clinical drawbacks of total lymphoid irradiation: the cons | Q68420806 | ||
| Morphological changes of the thymus and spleen with acute experimental allergic encephalomyelitis (EAE) in Lewis rats | Q68796452 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| secondary progressive multiple sclerosis | Q18965511 | ||
| P304 | page(s) | 1631-1646 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis | |
| P478 | volume | 167 |
| Q27487496 | Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection |
| Q64075120 | Bioinformatics Analyses Determined the Distinct CNS and Peripheral Surrogate Biomarker Candidates Between Two Mouse Models for Progressive Multiple Sclerosis |
| Q46567289 | Blocking type I interferon (IFN) signaling impairs antigen responsiveness of circulating lymphocytes and alters their homing to lymphoid organs: protective role of type I IFN. |
| Q37165250 | Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis. |
| Q88099238 | Diazoxide attenuates autoimmune encephalomyelitis and modulates lymphocyte proliferation and dendritic cell functionality |
| Q35027815 | Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler's virus infection |
| Q35589934 | Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). |
| Q34138616 | Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines |
| Q36126949 | Hippocampal protection in mice with an attenuated inflammatory monocyte response to acute CNS picornavirus infection |
| Q58122911 | Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model |
| Q36198757 | Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease? |
| Q36154032 | MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum |
| Q48173043 | Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade |
| Q37628560 | Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosis |
| Q34613664 | RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis |
| Q37645094 | Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice |
| Q36933909 | Regulatory role of CD1d in neurotropic virus infection |
| Q36004599 | Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity |
| Q48717930 | Study of anti-inflammatory effects of GB-115, a glycine-containing retropeptide cholecystokinin analog. |
| Q34646572 | Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis |
| Q28067131 | The Gas6/TAM System and Multiple Sclerosis |
| Q34203715 | The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice. |
Search more.